Canopy Growth Reports Fourth Quarter and Fiscal Year 2025 Financial Results

 Canopy Growth Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Canada cannabis revenue increased 4% in Q4 FY2025 year-over-year, led by 13% growth in Canada medical cannabis Reduced total debt by $293 million or 49% during FY2025 Refined strategy, focus and organizational structure expected to accelerate growth in global…

By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predic…